Dr. Joban Vaishnav

Paul Scheel, M.D., is a cardiologist at Johns Hopkins Medicine in Baltimore, Maryland with an expertise in Advanced Heart Failure and Transplant Cardiology. He is also an Assistant Professor of Medicine at the Johns Hopkins School of Medicine. Dr. Scheel provides clinical care to patients with heart failure, treating a wide range of conditions. He is an integral part of the Advanced Heart Failure and CCU inpatient services, and also provides service in the Cath Lab. Dr. Scheel earned his B.S. degree from the University of Notre Dame, majoring in Chemical and Biomolecular Engineering and minoring in Bioengineering. He obtained his M.D. degree from Washington University in St. Louis School of Medicine, where he was elected Alpha Omega Alpha. Following his medical degree, Dr. Scheel embarked on his training at Johns Hopkins Hospital. He completed his internship in Internal Medicine in 2017, followed by residency in Internal Medicine from 2017 to 2019. Driven by his passion for cardiovascular disease, he then pursued a fellowship in Cardiovascular Disease from 2019 to 2022. Building upon this foundation, he continued his training with a fellowship in Advanced Heart Failure and Transplant Cardiology, further honing his expertise in managing complex heart failure cases. He has been involved in research within the ARVC and LVAD Programs at Johns Hopkins and has a wider interest in genetic cardiomyopathies and durable mechanical support. Dr. Scheel is rated as an Experienced provider by MediFind in Tissue Biopsy. His top areas of expertise are Cardiomyopathy, Myocarditis, Heart Failure, Tissue Biopsy, and Heart Transplant.

Kavita Sharma MD, is an Associate Professor of Medicine in Advanced Heart Failure/Transplant Cardiology in the Division of Cardiology at the Johns Hopkins University School of Medicine. She is the Director of the Johns Hopkins Heart Failure with Preserved Ejection Fraction Program. She sees patients at The Johns Hopkins Hospital, downtown campus. A cardiologist specializing in advanced heart failure, her clinical interests include advanced heart failure diagnosis and management, heart transplantation, and mechanical circulatory support including left ventricular assist devices. She has a specialized interest in heart failure with preserved ejection fraction (HFpEF), and directs one of the largest programs in the country dedicated to caring for patients with this condition. She is the principal investigator of numerous clinical and translational trials in HFpEF and leads a team of nurses, research coordinators, and fellows-in-training in this multi-faceted program. She is an invited speaker at national meetings in topic areas covering advanced heart failure and HFpEF. Dr. Sharma is a member of the American Heart Association, the American College of Cardiology, the Heart Failure Society of America, and the International Society of Heart and Lung Transplantation. Dr. Sharma is rated as a Distinguished provider by MediFind in Tissue Biopsy. Her top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Cardiac Amyloidosis, Heart Transplant, and Fasciotomy.

Dr. Cingolani is an Associate Professor at The Johns Hopkins University School of Medicine, Division of Cardiology. He earned his medical degree from Universidad Nacional de La Plata, Argentina, and completed his Internship and Internal Medicine Residency at CEMIC, Buenos Aires, Argentina, and hypertension research post-doctoral fellowship at Henry Ford Hospital, Detroit, MI. After completing his Internal Medicine Residency at The Reading Hospital and Medical Center in Pennsylvania, Dr. Cingolani joined The Johns Hopkins Hospital as a Cardiology fellow, where he remained in the Faculty after his training. Currently, he is the Associate Director of The Johns Hopkins Hospital Coronary Care Unit, Director of the Hypertension Center and member of the Echocardiography Lab and Outpatient Cardiology Clinic. He also teaches pathophysiology to medical students. Dr. Cingolani’s research interests focus on hypertensive heart disease and its transition to heart failure. He aims to elucidate the mechanism/s by which certain matricellular proteins present in the heart seem to play a protective role. His research is mainly supported by the National Institute of Health (NIH). He is also the principal investigator of the DREAM study group, studying the effect of Melatonin in preventing atrial fibrillation in patients undergoing cardiac surgery. Dr. Cingolani has been recognized by the Council for High Blood Pressure Research of the American Heart Association for his work in hypertension and is the 2011 recipient of the PJ Schafer Memorial Heart Research Award, the 2012 Michel Mirowski Discovery Fund Award, and 2013 Magic that matters Fund. Dr. Cingolani is rated as an Advanced provider by MediFind in Tissue Biopsy. His top areas of expertise are Paroxysmal Supraventricular Tachycardia (PSVT), Multifocal Atrial Tachycardia, Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Cardiac Ablation, and Tissue Biopsy.